Roche Holding AG advanced the first project from its AI drug-discovery partnership with Recursion Pharmaceuticals, according to Bloomberg.
The move is an early test of whether artificial intelligence can identify new medicines.
ບົດຄວາມ
AI | Roche Advances AI-Derived Drug Target With Recursion
--・
ຂໍ້ຈຳກັດຄວາມຮັບຜິດຊອບ: ລວມເຖິງຄວາມຄິດເຫັນຈາກພາກສ່ວນທີສາມ. ບໍ່ແມ່ນຄຳແນະນຳ. Binance AI ອາດຈະຖືກນຳໃຊ້ໂດຍບໍ່ມີການຮັບປະກັນ. See T&Cs.